Ceragon Networks Ltd (CRNT) 2.22 $CRNT Ceragon Networks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ceragon Networks Ltd (CRNT) 2.22 $CRNT

Ceragon Networks (CRNT) Catches Eye: Stock Jumps 10.9%
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 7:30AM CDT
Ceragon Networks, Ltd. (CRNT) shares rose almost 11% in the last trading session.
CRNT: 2.22 (-0.04), DCM: 27.31 (+0.80)

5 Low Priced Breakout Stocks with Superlative Returns
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 9:21AM CDT
Betting on breakout stocks is one of the most popular methods used by active investors.
CRNT: 2.22 (-0.04), PRTS: 4.09 (-0.06), ENZ: 6.97 (+0.27), ARIS: 5.12 (-0.04), AUY: 5.71 (-0.16)

Ceragon Networks® Second Quarter 2016 Financial Results Scheduled for Release on August 8, 2016
PR Newswire - Thu Jul 07, 4:00AM CDT
Ceragon Networks Ltd. (NASDAQ: CRNT), the #1 wireless backhaul specialist, today is providing details of the conference call for its second quarter 2016 financial results. The Company will issue a press release announcing its results during pre-market hours on Monday, August 8, 2016.
CRNT: 2.22 (-0.04)

New Strong Buy Stocks for June 7th
Swarup Gupta - Zacks Investment Research - Tue Jun 07, 7:30AM CDT
New Strong Buy Stocks for June 7th
CRNT: 2.22 (-0.04), BMO: 64.12 (+0.35), ALV: 105.80 (+1.27), CM: 75.95 (+0.66), TAST: 12.11 (-0.02)

Three Mobile Operators in India Continue Large Scale Expansion of 4G Services with Ceragon's IP-20 Platform
PR Newswire - Mon Jun 06, 5:00AM CDT
Ceragon Networks Ltd. (NASDAQ: CRNT), the #1 wireless backhaul specialist, today announced that three mobile operators in India are continuing the large scale expansion of their 4G services with its IP-20 Platform. These Ceragon customers have placed orders totaling nearly $40 million, year to date, whereby approximately 25 percent of related revenue was recognized in Q1 and the remainder will be recognized in the coming quarters.
CRNT: 2.22 (-0.04)

New Strong Buy Stocks for June 3rd
Swarup Gupta - Zacks Investment Research - Fri Jun 03, 8:10AM CDT
New Strong Buy Stocks for June 3rd
CRNT: 2.22 (-0.04), AXLL: 32.65 (+0.04), ICD: 5.03 (+0.35), ENB: 41.13 (+2.04), LPX: 20.20 (-0.28)

5 Buy-Ranked Tech Stocks Posting Huge Price Gains In May
Zacks Premium Research - Zacks Investment Research - Wed Jun 01, 5:34PM CDT
Each of these stocks have gained over 20% in share price value over the last four weeks, so don't miss out!
CRNT: 2.22 (-0.04), NTES: 204.27 (-1.76), MKTO: 35.18 (+0.08), XLK: 46.45 (+0.17), ESNC: 0.33 (-0.01), MXPT: 10.18 (-0.67)

New Strong Buy Stocks for May 24th
Swarup Gupta - Zacks Investment Research - Tue May 24, 8:44AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday.
CRNT: 2.22 (-0.04), AXTI: 3.75 (-0.03), BWP: 16.71 (+0.29), AMAT: 26.29 (-0.33), EFSC: 28.76 (+0.50)

Leading Mobile Operator in South Cone Continues Rollout of its Large Scale 4G Network Modernization and Expansion Project with Ceragon
PR Newswire - Wed May 18, 4:00AM CDT
Ceragon Networks Ltd. (NASDAQ: CRNT), the #1 wireless backhaul specialist, today announced that a leading mobile operator in the Southern Cone of South America is continuing its multi-country, large scale 4G LTE expansion and modernization project using the IP-20 Platform. Following a successful rollout in 2015, this longstanding Ceragon customer placed follow-up orders totaling over $4.9 million, year to date, that began shipping in Q1 2016.
CRNT: 2.22 (-0.04)

What Falling Estimates & Price Mean for Cray (CRAY)
Zacks Equity Research - Zacks Investment Research - Fri May 13, 7:41AM CDT
Cray has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off
CRNT: 2.22 (-0.04), CRAY: 31.56 (-0.26)

Can The Uptrend Continue for Ceragon (CRNT)?
Zacks Equity Research - Zacks Investment Research - Thu May 12, 8:51AM CDT
Investors certainly have to be happy with Ceragon Networks Ltd. (CRNT) and its short term performance
CRNT: 2.22 (-0.04)

Ceragon Networks (CRNT) Catches Eye: Stock Rises 7.9%
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:25AM CDT
Ceragon Networks Ltd. (CRNT) shares rose almost 8% in the last trading session.
CRNT: 2.22 (-0.04), BBRY: 7.60 (-0.02)

Ceragon posts 1Q profit
Automated Insights - Mon May 09, 6:17AM CDT
TEL AVIV ISRAEL, Israel (AP) _ Ceragon Networks Ltd. (CRNT) on Monday reported first-quarter net income of $436,000, after reporting a loss in the same period a year earlier.
CRNT: 2.22 (-0.04)

Ceragon Networks Reports First Quarter 2016 Financial Results
PR Newswire - Mon May 09, 6:00AM CDT
Ceragon Networks Ltd. (NASDAQ: CRNT), the #1 wireless backhaul specialist today reported results for the first quarter ended March 31, 2016.
CRNT: 2.22 (-0.04)

Ceragon Networks® First Quarter 2016 Financial Results Scheduled For Release on May 9, 2016
PR Newswire - Mon Apr 11, 4:00AM CDT
Ceragon Networks Ltd. (NASDAQ: CRNT), the #1 wireless backhaul specialist, today is providing details of the conference call for its first quarter 2016 financial results. The Company will issue a press release announcing its results during pre-market hours on Monday, May 9, 2016.
CRNT: 2.22 (-0.04)

Ceragon Networks® Fourth Quarter 2015 Financial Results Scheduled for Release on February 16, 2016
PR Newswire - Mon Jan 11, 4:00AM CST
Ceragon Networks Ltd. (NASDAQ: CRNT), the #1 wireless backhaul specialist, today is providing details of the conference call for its fourth quarter 2015 financial results. The Company will issue a press release announcing its results during pre-market hours on Tuesday, February 16, 2016.
CRNT: 2.22 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 24

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

LightBox CRE Activity Index Sees Positive Response to Rates

Updated Category News Views 67

Introduction to LightBox's Findings Recent insights from LightBox reveal significant shifts in the commercial real estate (CRE) sector, highlighting increased activity in response to recent economic changes. As a leading provider of CRE information and technology, LightBox's Monthly CRE Activity Index plays a crucial role in tracking the dynamics of the market....

Continue Reading
Alliance Pharma's Recent Trading Activity on the LSE Explored

Updated Category News Views 167

Understanding Alliance Pharma's Trading Activity Alliance Pharma plc, known for its strategic positioning in the pharmaceutical market, has made a significant impact through its recent trading activities. These transactions are crucial for understanding the company's current standing and future potential in the market. The firm operates under the stock ticker LSE:INVP,...

Continue Reading
Icon Energy Corp. Welcomes M/V Bravo and Secures Funding

Updated Category News Views 83

Icon Energy Corp. Welcomes M/V Bravo and Secures Financing Icon Energy Corp. (“Icon”) (Nasdaq: ICON) is thrilled to announce the arrival of its latest fleet member, the M/V Bravo, alongside significant financing aimed at facilitating future growth. This advanced Kamsarmax dry bulk carrier represents a key achievement in Icon's operational strategy, paving the way for...

Continue Reading
Coinbase Investor Alert: Class Action Lawsuit Filed Against Company

Updated Category News Views 403

Traders braced for turmoil as Coinbase Global, Inc. (NASDAQ: COIN) found itself entangled in a significant class action lawsuit back in 2024, brought forth by the reputable law firm Bronstein, Gewirtz & Grossman. This isn’t just another legal skirmish; it’s an alarm bell ringing loudly for investors who acquired Coinbase securities during the defined Class Period....

Continue Reading
Danny Go! Launches Exciting New Toy Line with Just Play

Updated Category News Views 447

Danny Go! Launches Exciting New Toy Line Three new active-play toys inspired by the beloved YouTube series, Danny Go!, are set to hit shelves just in time for the holiday season. This innovative collaboration between Danny Go! and Just Play, a prominent toy company, aims to engage children through play, song, and dance. Exciting Toy Debut at Walmart The launch of these...

Continue Reading